[Targeted treatment of non-small cell lung cancer]

Area of Science:

• Oncology
• Molecular Biology
• Cancer Therapeutics

Background:

• Non-small cell lung cancer (NSCLC) was historically a leading cause of cancer mortality with increasing incidence, particularly in women.
• The perception of NSCLC has transformed due to significant advancements in understanding its molecular underpinnings.
• NSCLC now serves as a paradigm for developing targeted treatment strategies in oncology.

Purpose of the Study:

• To provide a comprehensive overview of current targeted treatment options for NSCLC.
• To highlight the evolution of NSCLC from a poorly understood disease to a model for precision medicine.
• To discuss the applicability of targeted therapies in NSCLC management.

Main Methods:

• Review of current literature on NSCLC targeted therapies.
• Analysis of molecular dependencies driving NSCLC.
• Examination of survival data and treatment outcomes.

Main Results:

• Targeted treatments are now available for nearly one-third of NSCLC patients.
• Molecularly targeted therapies have vastly improved survival times for NSCLC.
• NSCLC serves as a benchmark for molecular tumor board assessments in other cancers.

Conclusions:

• Targeted therapy represents a major breakthrough in NSCLC management.
• The NSCLC model is instrumental in advancing precision oncology across various cancer types.
• Continued research into molecular dependencies will further enhance NSCLC treatment efficacy.